Sale!

DES Gene Cardiomyopathy Dilated Type 1I NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The DES Gene Cardiomyopathy Dilated Type 1I NGS Genetic DNA Test is a comprehensive genetic analysis that identifies mutations in the DES gene associated with dilated cardiomyopathy type 1I. This advanced next-generation sequencing test provides crucial information for individuals with family history of heart conditions, unexplained cardiac symptoms, or those planning family expansion. The test helps identify inherited cardiac risks, enables early intervention strategies, and provides valuable insights for family members. Results are typically available within 3-4 weeks from blood or DNA samples. The test is priced at $500 USD with a regular price of $700 USD, making advanced genetic cardiac screening accessible to patients across the United States.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

DES Gene Cardiomyopathy Dilated Type 1I NGS Genetic DNA Test

Comprehensive Introduction to DES Gene Cardiomyopathy Testing

The DES Gene Cardiomyopathy Dilated Type 1I NGS Genetic DNA Test represents a breakthrough in cardiac genetic diagnostics, offering precise detection of mutations in the desmin (DES) gene associated with dilated cardiomyopathy type 1I. This inherited condition affects the heart muscle’s ability to pump blood effectively, leading to progressive heart failure if left undetected. Our advanced next-generation sequencing technology provides unparalleled accuracy in identifying genetic variants that predispose individuals to this serious cardiac disorder.

Early genetic identification through this test enables proactive medical management and personalized treatment strategies. The DES gene encodes desmin, a crucial protein that forms the structural framework of muscle cells, particularly in cardiac tissue. Mutations in this gene disrupt normal muscle function, leading to the characteristic dilation and weakening of the heart chambers seen in dilated cardiomyopathy.

What the Test Measures and Detects

This comprehensive genetic analysis specifically targets:

  • Complete sequencing of the DES gene using next-generation sequencing technology
  • Identification of pathogenic variants, including missense, nonsense, and frameshift mutations
  • Detection of single nucleotide polymorphisms (SNPs) associated with dilated cardiomyopathy risk
  • Analysis of gene regions critical for desmin protein structure and function
  • Assessment of variant pathogenicity through advanced bioinformatics analysis

Advanced NGS Technology Benefits

Our next-generation sequencing approach provides superior detection capabilities compared to traditional genetic testing methods. The technology enables:

  • High-resolution analysis of the entire DES gene coding region
  • Simultaneous detection of multiple mutation types
  • Enhanced sensitivity for rare genetic variants
  • Comprehensive coverage of known and novel mutations

Who Should Consider This Genetic Test

This test is particularly recommended for individuals experiencing:

  • Unexplained shortness of breath or fatigue during routine activities
  • Family history of dilated cardiomyopathy or sudden cardiac death
  • Abnormal heart rhythms or palpitations without clear cause
  • Progressive exercise intolerance or reduced physical stamina
  • Swelling in legs, ankles, or feet due to fluid retention
  • Individuals planning pregnancy with family cardiac history
  • First-degree relatives of confirmed DES mutation carriers

Clinical Indications for Testing

Healthcare providers typically recommend this test for patients presenting with:

  • Echocardiogram findings suggestive of dilated cardiomyopathy
  • Cardiac MRI abnormalities consistent with inherited heart disease
  • Progressive cardiac symptoms in young or middle-aged adults
  • Multiple family members affected by similar cardiac conditions

Significant Benefits of Genetic Testing

Undergoing the DES Gene Cardiomyopathy test provides numerous advantages:

  • Early Risk Identification: Detect genetic predisposition before symptom onset
  • Personalized Treatment Planning: Tailor medical interventions based on genetic profile
  • Family Screening Guidance: Identify at-risk relatives for proactive monitoring
  • Reproductive Planning: Make informed decisions about family expansion
  • Psychological Relief: Reduce uncertainty through definitive genetic information
  • Preventive Care Optimization: Implement lifestyle modifications and monitoring protocols

Understanding Your Test Results

Our comprehensive genetic counseling support helps you interpret your results:

Positive Result Interpretation

A positive result indicates the presence of a pathogenic DES gene mutation. This finding:

  • Confirms genetic predisposition to dilated cardiomyopathy type 1I
  • Enables implementation of targeted surveillance and preventive measures
  • Provides opportunity for family member testing and risk assessment
  • Guides appropriate medical management with cardiology specialists

Negative Result Interpretation

A negative result suggests no detectable DES gene mutations. This outcome:

  • Significantly reduces genetic risk for DES-related cardiomyopathy
  • May indicate need for evaluation of other genetic causes
  • Provides reassurance for family planning decisions
  • Does not completely eliminate risk of other cardiac conditions

Variant of Uncertain Significance

Some results may identify genetic changes with unclear clinical implications. In such cases:

  • Additional family studies may be recommended
  • Ongoing research may provide future clarity
  • Clinical monitoring remains important based on symptoms
  • Periodic re-evaluation of variant classification may be necessary

Test Pricing and Details

Test Component Details
Test Name DES Gene Cardiomyopathy Dilated Type 1I NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood or Extracted DNA or One drop Blood on FTA Card
Pre-test Requirements Clinical History and Genetic Counseling Session

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and cardiology specialists ensures comprehensive care regardless of your location.

Simple Testing Process

Our streamlined testing process includes:

  • Pre-test genetic counseling to discuss implications and expectations
  • Convenient sample collection at our nationwide facilities
  • Advanced laboratory analysis using cutting-edge NGS technology
  • Comprehensive result interpretation with board-certified geneticists
  • Post-test counseling to discuss results and next steps

Take Control of Your Cardiac Health Today

Don’t let uncertainty about your genetic cardiac risk affect your quality of life. Our DES Gene Cardiomyopathy Dilated Type 1I NGS Genetic DNA Test provides the clarity you need to make informed health decisions and protect your cardiac future.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our compassionate team is ready to guide you through every step of the genetic testing process and help you understand your cardiac health risks.

Early detection through genetic testing can significantly impact disease management and family planning. Take the first step toward comprehensive cardiac risk assessment by contacting our specialists today.